Key facts
- ByHeart’s last known valuation is $757.3M (Mar 2025).
- It has raised $467.2M across 6 recorded rounds; the latest was Later Stage VC ($72.2M) in Mar 2025.
- Notable investors include Gaingels, D1 Capital Partners, Calm Ventures, Evolution VC Partners, Polaris Partners — 13 tracked in total.
- ByHeart has filed 8 Form Ds with the SEC since 2019, most recently May 2025 ($95.5M sold to 46 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for ByHeart
Funding rounds
6 roundsAbout ByHeart
Operator of an infant nutrition company intended to offer nutritious food for babies. The company's products are made from hand-picked ingredients using small-batch blending and sit at the forefront of immune, microbiome, cognitive, and digestive health, providing parents with choices so they can proactively create a strong foundation for their babies' future health.
- Industry
- Food Products
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2016
- Employees
- 208
- Website
- byheart.com/
- Ownership
- Privately Held (backing)
ByHeart doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ByHeart shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ByHeart in its N-PORT filings yet. We sweep new filings monthly.